Small Business

Strides Arcolab, Pfizer in pact to sell drugs in US

Strides Arcolab announced a collaboration with Pfizer, USA on Thursday where Pfizer will commercialise the later"s off-patent sterile injectables and oral products in the US. - Strides Arcolab soars on Pfizer deal - Pfizer to source 40 off-patent cancer care drugs from Strides - TCG Life signs pact with Pfizer - Dr Reddy"s plans to launch Lipitor"s generic version in US - Strides Arcolab ends court process for merger - SEC probes 9 deals for insider-trading violations These finished dosage form products will be licensed and supplied by Strides and two South Africa-based JVs of Strides where Strides holds 50%. Pfizer will commercialise around 40 off-patent products in the oncology area. The first product will be launched this year.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):